RxDoctor Payments Data

David Allen

Foot Surgery · New Port Richey, FLNPI 1982746863

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.9% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Amgen at 25.2% of the total. Reporting peaked in 2022 at $398 and has fallen 68.3% since, to $126 in 2025.

$1,627in general payments, 2019–2025

Across 70 payments — averaging $23.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$410
  • Paratek Pharmaceuticals, Inc.$333
  • Smith+Nephew$133
  • Merck$123
  • Organogenesis Inc.$109
  • Comsort, Inc$100
  • plus $419 from 16 others

What the payments were for

  • Consulting fees$1006%
  • Food & beverage$1,52794%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,627 in reported general payments places this provider in the 70th percentile of 107 foot surgery providers in Florida.

See all foot surgery providers in Florida

Medicare billing

Part B allowed, 2024
$336,188
Medicare patients
1,133
Services billed
5,704

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole156$4,410
Gabapentin36$492
Ammonium Lactate27$361
Methylprednisolone42$299
Doxycycline Hyclate19$266
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$187
Meloxicam30$159
Ciprofloxacin Hcl22$157
Cephalexin24$147
Allopurinol11$107
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$77

Paid to pharmacies, not to this prescriber.

Other foot surgery in New Port Richey

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →